Condensed Consolidated Statements of Changes in Stockholders Equity (Deficit) (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Sub Total	Noncontrolling Interest
Balance, shares at Dec. 31, 2023		4,046,760
Balance, amount at Dec. 31, 2023	$ (49,525)	$ 4,047	$ 35,826	$ (89,398)	$ (49,525)	$ 0
Imputed interest	1,329	$ 0	1,329	0	1,329	0
Net loss	(50,217)			(50,217)	(50,217)	0
Balance, shares at Mar. 31, 2024		4,046,760
Balance, amount at Mar. 31, 2024	(98,413)	$ 4,047	37,155	(139,615)	(98,413)	0
Balance, shares at Dec. 31, 2023		4,046,760
Balance, amount at Dec. 31, 2023	(49,525)	$ 4,047	35,826	(89,398)	(49,525)	0
Imputed interest	3,321
Net loss	(285,672)
Forgiveness of loan payable to related party	104,696
Balance, shares at Sep. 30, 2024		4,046,760
Balance, amount at Sep. 30, 2024	(227,180)	$ 4,047	143,843	(375,070)	(227,180)	0
Balance, shares at Mar. 31, 2024		4,046,760
Balance, amount at Mar. 31, 2024	(98,413)	$ 4,047	37,155	(139,615)	(98,413)	0
Imputed interest	1,992	$ 0	1,992	0	1,992	0
Net loss	(45,272)			(45,272)	(45,272)	0
Balance, shares at Jun. 30, 2024		4,046,760
Balance, amount at Jun. 30, 2024	(141,693)	$ 4,047	39,147	(184,887)	(141,693)	0
Net loss	(190,183)	0	0	(190,183)	(190,183)	0
Forgiveness of loan payable to related party	104,696	$ 0	104,696	0	104,696	0
Balance, shares at Sep. 30, 2024		4,046,760
Balance, amount at Sep. 30, 2024	(227,180)	$ 4,047	143,843	(375,070)	(227,180)	0
Balance, shares at Dec. 31, 2024		4,046,760
Balance, amount at Dec. 31, 2024	(302,102)	$ 4,047	143,843	(458,919)	(311,029)	8,927
Net loss	(486,397)			(486,247)	(486,247)	(150)
Stock-based compensation, shares		221,000
Stock-based compensation, amount	408,850	$ 221	408,629	0	408,850	0
Issuance of common stock as commitment shares, shares		135,000
Issuance of common stock as commitment shares, amount	249,750	$ 135	249,615	0	249,750	0
Issuance of common stock for conversion of convertible note, shares		5,117,333
Issuance of common stock for conversion of convertible note, amount	153,520	$ 5,117	148,403	0	153,520	0
Balance, shares at Mar. 31, 2025		9,520,093
Balance, amount at Mar. 31, 2025	23,621	$ 9,520	950,490	(945,166)	14,844	8,777
Balance, shares at Dec. 31, 2024		4,046,760
Balance, amount at Dec. 31, 2024	(302,102)	$ 4,047	143,843	(458,919)	(311,029)	8,927
Imputed interest	0
Net loss	(27,965,403)
Forgiveness of loan payable to related party	0
Balance, shares at Sep. 30, 2025		47,869,093
Balance, amount at Sep. 30, 2025	14,208,453	$ 47,869	42,592,082	(28,429,710)	14,210,241	(1,788)
Balance, shares at Mar. 31, 2025		9,520,093
Balance, amount at Mar. 31, 2025	23,621	$ 9,520	950,490	(945,166)	14,844	8,777
Net loss	(6,600,770)	$ 0	0	(6,600,618)	(6,600,618)	(152)
Stock-based compensation, shares		3,395,000
Stock-based compensation, amount	6,651,250	$ 3,395	6,647,855	0	6,651,250	0
Balance, shares at Jun. 30, 2025		12,915,093
Balance, amount at Jun. 30, 2025	74,101	$ 12,915	7,598,345	(7,545,784)	65,476	8,625
Net loss	(20,878,236)	$ 0	0	(20,877,551)	(20,877,551)	(685)
Stock-based compensation, shares		11,954,000
Stock-based compensation, amount	20,828,790	$ 11,954	20,816,836	0	20,828,790	0
Issuance of common stock for acquisition of Goldfinch Group Holdings Ltd., shares		3,000,000
Issuance of common stock for acquisition of Goldfinch Group Holdings Ltd., amount	(15,000)	$ 3,000	(3,000)	(6,375)	(6,375)	(8,625)
Issuance of common stock for acquisition of SolanAI Global Ltd., shares		10,000,000
Issuance of common stock for acquisition of SolanAI Global Ltd., amount	12,498,798	$ 10,000	12,489,901	0	12,499,901	(1,103)
Issuance of common stock for acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd., shares		10,000,000
Issuance of common stock for acquisition of Xirangsheng (Shenzhen) Health Technology Co., Ltd., amount	1,700,000	$ 10,000	1,690,000	0	1,700,000	0
Balance, shares at Sep. 30, 2025		47,869,093
Balance, amount at Sep. 30, 2025	$ 14,208,453	$ 47,869	$ 42,592,082	$ (28,429,710)	$ 14,210,241	$ (1,788)